According to foreign media reports, Swiss scientists have recently developed a miniature blood laboratory, which is very small and can be implanted under the skin to monitor human health in real time.
It is reported that the device is 14 millimeters long and can be used to update medical staff's health information through the mobile phone in time. According to the research team of the Federal Institute of Technology in Lausanne, Switzerland, this sensor device is very important for patients undergoing chemotherapy. It can prevent key heart attacks by monitoring key chemical components in the blood flow.
The volume of this implant is only a few cubic millimeters, but it has 5 sensors, a wireless transmitter and a power transmission system. This design allows the implant to help physicians monitor high-risk patients anywhere. Outside the human body, a battery pack can provide 0.1 watts of electrical energy through the human skin, so it is only necessary to replace the battery each time without changing the implant, which is convenient to operate.
The advent of this sensor will change the previous treatment of patients. Using this system can continuously and directly monitor the patient's individual tolerance, without the need for age, weight data and weekly blood tests as treatment reference information.
In order to monitor key substances in the body, such as lactate and glucose, the surface of each sensor is covered with enzymes. Basically, this instrument can detect any important information of human body. However, the disadvantage of this design is that all enzyme coatings have a service life. The key to the next optimization is to extend the use time of the enzyme coating on the sensor as much as possible from the design. At present, this enzyme coating can be tested for 1.5 months of continuous use, which is sufficient for many applications.
In addition, the implant is very small and very easy to remove and replace. For patients with chronic diseases, it can send warning messages before symptoms appear and implement effective medical measures. It is expected that within four years, this new implant will be sold commercially. It is not difficult to imagine that after the implant is put into use, it will be easier to monitor patients and facilitate scientific treatment.
module sofas,modern office sofa,office reception sofa
Feat Top International(China) CO.,LTD , https://www.nbfeattop.com